Literature DB >> 1336949

Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.

E Brummer1, P R Bhagavathula, L H Hanson, D A Stevens.   

Abstract

We examined in vitro interaction between the azole antifungal agents itraconazole and ketoconazole and macrophages and their activities against Blastomyces dermatitidis. Fungistatic and fungicidal concentrations for B. dermatitidis in vitro were assessed in a microculture system in which fungistasis was measured as inhibition of multiplication and fungicidal activity was measured as reduction of inoculum CFU. Resident peritoneal murine macrophages, which surround but do not phagocytize the fungus, were not fungicidal for B. dermatitidis isolates but were fungistatic for some isolates studied. Synergy was demonstrated when fungistatic concentrations (e.g., 0.01 micrograms/ml) of itraconazole, which limited growth 55% compared with that of controls, were cocultured with macrophages; this resulted in fungicidal activity (85% killing) against B. dermatitidis (ATCC 26199) in 72-h assays. This synergy could occur even if itraconazole was added after the macrophages had surrounded the fungus. Ketoconazole at fungistatic concentrations did not act synergistically with macrophages to kill B. dermatitidis. Lymph node lymphocytes could not substitute for macrophages in synergy with itraconazole to kill B. dermatitidis. When B. dermatitidis was separated by a filter from macrophages in Transwell cultures, fungicidal synergy with itraconazole was less efficient. Pretreatment of B. dermatitidis with itraconazole for 24 h did not render the fungus susceptible to killing by macrophages in the absence of itraconazole, whereas pretreatment of nonfungistatic macrophages with itraconazole rendered them fungistatic in a dose-dependent manner. Three other isolates were killed by otherwise fungistatic concentrations of itraconazole when the isolates were cocultured with macrophages. These findings indicate that one basis for the efficacy of itraconazole versus ketoconazole in treating blastomycosis could be synergy of a fungistatic concentration of itraconazole with macrophages in killing of B. dermatitidis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336949      PMCID: PMC284359          DOI: 10.1128/AAC.36.11.2487

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  The activity of ketoconazole and itraconazole against Aspergillus fumigatus in mixed cultures with macrophages or leukocytes.

Authors:  F Aerts; J Van Cutsem; M De Brabander
Journal:  Mykosen       Date:  1986-04

2.  Sensitivity testing with ketoconazole in an assay containing Candida albicans, human polymorphonuclear leukocytes and serum.

Authors:  T M Bauer; W Kronsteiner; M Bassler; F D Daschner
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

3.  Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole.

Authors:  A Ganer; E Arathoon; D A Stevens
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

4.  Effects of antifungal agents on the function of human neutrophils in vitro.

Authors:  E Roilides; T J Walsh; M Rubin; D Venzon; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

5.  Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.

Authors:  F C Odds; C E Webster
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

6.  Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.

Authors:  J W Van 't Wout; I Meynaar; I Linde; R Poell; H Mattie; R Van Furth
Journal:  J Antimicrob Chemother       Date:  1990-05       Impact factor: 5.790

Review 7.  The clinical pharmacokinetics of itraconazole: an overview.

Authors:  J Heykants; A Van Peer; V Van de Velde; P Van Rooy; W Meuldermans; K Lavrijsen; R Woestenborghs; J Van Cutsem; G Cauwenbergh
Journal:  Mycoses       Date:  1989       Impact factor: 4.377

8.  The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans.

Authors:  M de Brabander; F Aerts; J van Cutsem; H van den Bossche; M Borgers
Journal:  Sabouraudia       Date:  1980-09

9.  Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters.

Authors:  R P Harvey; E S Schmid; C C Carrington; D A Stevens
Journal:  Am Rev Respir Dis       Date:  1978-04

10.  Modification of polymorphonuclear leucocyte function by imidazoles.

Authors:  B Rowan-Kelly; A Ferrante; Y H Thong
Journal:  Int J Immunopharmacol       Date:  1984
View more
  6 in total

1.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Quantitation of azoles and echinocandins in compartments of peripheral blood by liquid chromatography-tandem mass spectrometry.

Authors:  Fedja Farowski; Oliver A Cornely; Jörg J Vehreschild; Pia Hartmann; Tim Bauer; Angela Steinbach; Maria J G T Rüping; Carsten Müller
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 3.  Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.

Authors:  M Haria; H M Bryson; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

4.  The antifungal agent itraconazole induces the accumulation of high mannose glycoproteins in macrophages.

Authors:  Tiffany Frey; Antonio De Maio
Journal:  J Biol Chem       Date:  2009-05-04       Impact factor: 5.157

5.  Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.

Authors:  Cristina Gil-Lamaignere; Emmanuel Roilides; Juan Mosquera; Avgi Maloukou; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

Review 6.  Animal models of zygomycosis--Absidia, Rhizopus, Rhizomucor, and Cunninghamella.

Authors:  K Kamei
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.